Skip to content

Effects of Training with Solo and Apparatus Pilates on improving the Cardiorespiratory and Metabolic Systems of hypertensive patients using medicines.

Chronic effects of the Pilates Method on cardiorespiratory and metabolic responses in controlled hypertensive women

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-78b6zky
Enrollment
Unknown
Registered
2021-09-09
Start date
2019-07-03
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exercise Movement Techniques

Interventions

Control Group (CG): it will be formed by 20 hypertensive and controlled women from the Baixada Santista aged between 30 and 59 years old until the end of the intervention. the CG will be without train
E02.779.474

Sponsors

Universidade Federal de São Paulo - UNIFESP
Lead Sponsor
Universidade Federal de São Paulo - UNIFESP
Collaborator

Eligibility

Sex/Gender
Female
Age
30 Years to 59 Years

Inclusion criteria

Inclusion criteria: Be controlled hypertensive; regardless of the class of medication used and the combination of two or more medications; be between 30 and 59 years of age; be sedentary for at least six months; have a body mass index of up to 30 kilos per square meter; not using contraceptives or under hormonal replacement; having medical clearance to practice physical exercise; not having osteomioarticular disease that could compromise the partial or total performance of the proposed exercises; not having any other disease that could compromise the cardiovascular; respiratory or metabolic to exercise; do not have diabetes mellitus; do not smoke or drink alcohol; do not have damage to a target organ; such as nephropathy; heart disease; etc. and accept to be a project volunteer. Only women with BP will be included in the study. Controlled; that is; who are undergoing drug treatment of any class. All volunteers included in the study signed an informed consent form.

Exclusion criteria

Exclusion criteria: Women who during the experimental period 4 months; have changes in drug treatment as class; dose; drug interaction and those who; at the end of 16 weeks of physical training; have a frequency below 75% or who have had two or more consecutive absences in training.

Design outcomes

Primary

MeasureTime frame
Improvement in biochemical (metabolic) parameters assessed by laboratory tests performed before and after the intervention period.;Improvement/increase in respiratory capacity (inspiratory and expiratory) of at least 20%, assessed by the Pulmonary Function Test (Spirometry) before and after the intervention period.;Improvement in cardiorespiratory capacity and physical conditioning, assessed by the cardiorespiratory exercise test - maximal effort test, before and after the intervention period.;Diastolic blood pressure reduction, on average 3mmHg, assessed by ECG and ABPM before and after the intervention period.;Systolic blood pressure reduction, on average of 7mmHg, assessed by ECG and ABPM before and after the intervention period.

Secondary

MeasureTime frame
Improvement in anthropometric indices, assessed by stadiometer and measuring tape, before and after the intervention period.

Countries

Brazil

Contacts

Public ContactRodrigo Barbosa
digobarbosa@yahoo.com.br+55-011-999968094

Outcome results

None listed

Source: REBEC (via WHO ICTRP)